Skip to content

FDA Approves Esketamine For Major Depression, Fastest Acting Drug

Esketamine has been approved this week by the The Food and Drug Administration (FDA) to treat major depression. Esketamine is the first major depression treatment to hit the U.S. market in decades. Best of all, it gives patients who no longer respond to current drugs, new hope for a good quality of life. In addition,…

Read More

This will close in 0 seconds

Scroll To Top